List of Contract Manufacturing Companies in California - 53

High throughput engineering of cell lines to enhance the design and manufacture of next-generation therapeutics.

Abeomics Inc. is founded by scientists for the scientists. Our immunologists, cell biologists and business professionals have contributed for over 25 years to the growth and success of global companies including BD Biosciences, eBioscience and IMGENEX Corporation. We bring our experiences to develop well-validated and specific antibodies by traditional hybridoma technology and by genetic engineering to produce recombinant mouse and rabbit monoclonal antibodies.

Serving the SynBio materials, foods and pharma industries with comprehensive facilities/equipment service programs, We help customers optimize their processes with the most cost effective systems, services, and processes to keep them running on schedule and in budget. Facilities/Equipment Performance Management Service Contracts Upstream Process Consulting - Bioreactor specification - Sensors, Sampling solutions - Automation - Integration Downstream Process Consulting - Filtration - Chromatography - Separations - Drying Calibration – instruments measuring -Temperature - Pressure - Flow - Mass - Optical - Volumetric - Dimensional NIST traceable "cradle to grave" calibration - Performance - Logging - SOP's - Records management Validation – IOQ generation, execution and reports OEM Post Sale Services Management - Installation - Calibration - Integration - On-site Services - Mail-in or Remote Service Center repairs - Warranty Record and Services Management Laboratory/Plant - automation, integration and maintenance Labor Services - field and contract service Equipment Sales - OEM supporting services in process design and performance service contracts - OEM Services Partners include;; Sonotec Non-invasive Flow Meters, BlueSens offgas Analyzers, APS Corp. Industrial Bioprocess Systems, Chemglass Labware, Hamilton Instruments, SecureCell Laboratory Automation

Improve yield, reduce deviations, and ensure product quality in GxP pharmaceutical manufacturing with real-time, practical Artificial Intelligence (AI)- powered software as a service solutions.

Allele Biotechnology and Pharmaceuticals, Inc. is a private, San Diego-based company that explores the mechanisms of biological processes to develop technologies and products for biomedical researchers. The company was founded by scientists and other professionals with the goal of advancing discovery and innovation. Our mission is to increase accessibility to innovative molecular biology research tools by offering cutting edge products at a reasonable cost, and providing excellent customer service in addition to the technical knowledge needed to facilitate their use. Our knowledgeable scientists and technicians are available to answer questions regarding any of our products. Over the past decade, Allele has become a reliable source for a wide variety of Molecular Biology reagents, superior fluorescent proteins, camelid derived nano antibodies (nAb), cellular reprogramming services and reagents, and immundiagnostic kits and various other products and custom services.

Alpha Medical Instruments,developer, manufacturer, Balloon flotation catheters, venous catherization, right heart, measurements, venous, pulmonary artery pressures, cardiac output

Established in 1993 in California, USA, Amsino is a leading medical device developer and manufacturer dedicated to advancing healthcare worldwide by developing, manufacturing, and marketing medical products that help improve the safety and effectiveness of patient care. The Amsino product portfolio includes Sterile Water and Saline, IV Therapy, Waste Fluid Management, Respiratory, Urology, and Enteral Feeding products. Amsino products are distributed in the United States and more than 80 countries worldwide. Visit www.amsino.com for our complete product offering.

Applied Viromics is a biotech company aiming to support early drug discovery and development activities. Applied Viromics specializes in custom-made recombinant viral vectors for efficient gene delivery both in vitro and in vivo.

Apurun specializes in tech transfer development and GMP manufacturing services for nanoparticle pharmaceuticals and nanomedicines. Their comprehensive approach enables and supports the development of nanoparticle pharmaceuticals.

Argonaut Manufacturing Services is a contract manufacturing company that provides supply chain technologies for biopharmaceutical, diagnostics, and life science organizations. They offer services such as aseptic fill finish manufacturing, IVD manufacturing, and high-yield manufacturing. The company is dedicated to serving highly innovative companies in the industry.

Since our inception in January of 2006, Assay Biotechnology has been a worldwide contributor of industry-leading antibody and assay technologies, fluorescent dyes, quenchers, recombinant proteins and synthetic peptides. Located in the heart of California's San Francisco Bay Area, we have strived to answer the global need for high quality assay kits and immunological reagents used in academic and pharmaceutical research that formulate the basis of healthcare. For the first couple years after our founding, Assay Biotech established itself as an antibody manufacturer, catering specifically to large corporations through OEM partnerships. Since then, we have been emerging as a prominent assay and antibody source, expanding our reach to millions of researchers in over 50 countries around the world. We are determined to become one of the world's leading assay development and manufacturing companies, providing a multitude of ready-to-use assays, immunological reagents, molecular detection modules and biomarkers to support the most arduous academic and pharmaceutical research endeavors.

AuST is a medical device design, development, and manufacturing firm specializing in minimally invasive medical devices. We excel at collaborative development and have taken numerous products from concept to market using a process that focuses on rapid design iteration and ample clinical feedback. Our design expertise is supported by in-depth experience with quality management and US and European regulatory systems. We maintain a fully resourced product development lab and pilot production facility in Mountain View, California. We also maintain volume manufacturing capability in Salt Lake City, Utah. In addition to our development capabilities, we offer a number of novel technologies that can enhance device performance and manufacturability.

Avid Bioservices (NASDAQ:CDMO), is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biologics. The company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology, biopharmaceutical, and cell & gene therapy industries. With over 30 years of experience, Avid's services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the company provides a variety of process development activities, including upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of our services ranges from standalone process development projects to full development and manufacturing programs through commercialization. Please be aware that the FBI recently issued a warning about an increased number of fake job postings for remote work employment that target applicants' personally identifiable information. All approved Avid Bioservices positions are accessible via the Avid Bio Careers page at https://avidbio.com/careers/.

AxisPharm is a San Diego based antibody drug conjugate (ADC) linker product and service provider. At AxisPharm, we focus on manufacturing novel ADC linkers, site specific molecular probes and advanced biochemical reagents. We also provide a variety of bio/chemical services worldwide, including custom synthesis and integrated drug discovery services.

Bakhu Holdings, Corp. produces, manufactures, and sells cannabis-related byproducts for medical, food additive, and recreational use. The company was founded in 2018 and is based in Long Beach, California.

BioDuro-Sundia, an Advent International portfolio company is a trusted, leading contract research development, and manufacturing organization (CRDMO) for over 28 years. We provide our biotech and pharmaceutical partners with fully integrated services to support their efforts from target identification through to commercial drug product manufacturing. The company is based in the US with operations in China, totaling 2,000+ employees and 7 global sites across 6 cities. Core expertise includes small and large molecule discovery, development and scale-up, support for IND submission, and unique technology platforms such as bioavailability enhancement of insoluble compounds. The one-stop-shop operation helps biotech and pharma partners across the globe to significantly accelerate discovery and de-risk development to create higher value outcomes. We adhere to one global highest standard of compliance and business operation code. Science-driven, customer-oriented, flexible, people-focused culture enables us to provide top-tier integrated, fast and flexible tailored services to our customers to meet their unique needs and accelerate our development timeline. For more information about BioDuro-Sundia, please visit our website at www.bioduro-sundia.com

Bionova Scientific is a dynamic, full service, biologics Contract Development and Manufacturing Organization (CDMO) on a mission to deliver the highest quality process development and manufacturing services to biologic drug development companies around the world. Bionova's renowned scientific expertise and dedication to its customers helps life changing therapies arrive to the market faster and more efficiently. At the heart of Bionova is a team of highly dedicated experts combining strong experience in cGMP biologics manufacturing and process development, with a technology-focused approach and a deep knowledge of the industry. From early stage research material generation to Process Development and GMP manufacturing, Bionova's teams are fully committed to helping their clients fulfill their objective of providing sustainable and affordable therapies to their patients.

Bioserv Corporation located in San Diego, California is a boutique cGMP contract manufacturing organization (CMO) serving the pharmaceutical, biotechnology, life sciences, medical device, and diagnostic industries since 1988. Bioserv’s core competency is manual filling which allows us to be very flexible and capable of handling small to medium batches effortlessly. Bioserv has a broad range of manufacturing suites to meet your production needs. Bioserv’s manufacturing facilities include certified Class 10,000 (Class 7 or Class C), Class 100 (Class 5 or Class A) areas, and Uncontrolled laboratory rooms. Whether a client is looking to move a drug product candidate into the pre-clinical setting, Phase I, Phase II clinic, or looking for basic reagent formulation and filling expertise, Bioserv has the experience and capabilities to get our clients there on time. We have filled a significant number of cGMP finished drug product lots for our clients to support their Phase I and Phase II clinical trial needs. We have a broad level of highly skilled production experts that have worked with very complex formulations, including liposomes, emulsions, nano-particles, small molecules, conjugates, and adjuvants. We understand that each product has its own unique set of manufacturing requirements. Bioserv is committed to making sure that those products are made with the highest Quality Standards each and every time. Work-From-Home Job Scam Alert It has been brought to our attention that job seekers are being contacted by scammers misrepresenting themselves as Bioserv recruiters. These scammers are contacting job seekers on LinkedIn or other job sites asking job seekers to apply for fake work-from-home positions. Please be advised that Bioserv does not generally offer work-from-home positions and all job listings are available here: https://sorrentotherapeutics.com/careers/. Any communication regarding recruitment will be done via email domain ending in @sorrentotherapeutics.co

• The Cedars-Sinai Biomanufacturing Center (CBC) is a new 25,000 square feet, state-of-the-art biomanufacturing facility located in West Hollywood, California. • Manufacturing the next generation of cell and gene therapies for human IND-enabling clinical trials. • cGMP cell manufacturing facility housing multiple cleanroom cell production suites and process development laboratories. • Combined expertise in a cGMP-compliant approach to manufacture cells at scale with innovative technologies and equipment. • Transferring laboratory protocols to cGMP, up-scaling of processes and achieving Food and Drug Administration standards to bring innovative cell therapy solutions to researchers and translational scientists. • World-class expertise in stem cell (iPSC) biology, gene editing and bioprocessing. • Supporting California Institute for Regenerative Medicine (CIRMN) programs, CBC is providing a much-needed cell biomanufacturing center in California

Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications.

Founded in 2001, we are the third largest peptide-focused contract research, development, and manufacturing organization (“CRDMO”) worldwide in terms of sales revenue in 2023, according to Frost & Sullivan. We are also considered one of the most comprehensive peptide-focused CRDMO globally (Frost & Sullivan), offering complete life-cycle support from early-discovery, pre-clinical research and clinical development to commercial production. We mainly provide (i) contract research organization (“CRO”) services, including peptide new chemical entity (“NCE”) discovery synthesis; (ii) contract development and manufacturing organization (“CDMO”) services, including peptide chemistry, manufacturing, and controls (“CMC”) development; and (iii) contract manufacturing organization (“CMO”) services, including peptide NCE and generic drug commercial manufacturing. We have established global operations, with projects covering over 50 countries, including major markets in the United States, China, Japan, Europe, South Korea, and Australia. We also provide customers wit peptide drug development, production, and CMC filing support services that meet regulatory requirements in major markets worldwide. In addition to peptides, we have developed a diverse project pipeline focusing on various types of complex peptide- and oligonucleotide-based new chemical entities (“NCEs”). Our peptide conjugation services seamlessly integrate our peptide and oligonucleotide platforms to produce a wide range peptide conjugates products. The introduction of our PeptiConjuXTM and PeptiNuclide LinkTechTM are dedicated to the development and large-scale manufacturing (i.e., kilogram-scale) of peptide-oligonucleotide conjugates (“POC”), peptide drug conjugates (“PDC”), and radionuclide drug conjugates (“RDC”). As of December 31, 2023, we had successfully synthesized approximately 1,800 molecules through these two platforms.

Culture is your bioreactor lab, in the cloud. We help scientists accelerate bioprocess development with our high-throughput bioreactor cloud lab. You design your experiment, and we execute the experiment in our lab using our 250mL bioreactors. We take care of the high-quality execution so that you can focus on developing processes. While your experiment runs in our lab, you can monitor and analyze your data in real time using our online dashboard. With Culture, get faster insights to make better, data-driven decisions.

CURE Pharmaceutical is an innovative drug delivery and development company committed to improving drug efficacy, safety and the patient experience through its proprietary drug dosage forms and delivery systems. CURE has an industry leading full-service cGMP manufacturing facility and is a preeminent developer and manufacturer of a patented and proprietary delivery system (CureFilm™), the most advanced oral thin film on the market today. CURE has developed an array of products in cutting-edge delivery platforms and partners with leading pharmaceutical companies. CURE has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector with partnerships in the U.S., Canada, Israel and Germany, among other markets. Our mission is to improve people's lives by redefining how medicines are delivered and experienced.

Dendreon is a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy. Dendreon’s flagship product, PROVENGE (sipuleucel-T), was the first FDA-approved immunotherapy made from a patient’s own immune cells. More than 40,000 men with advanced prostate cancer have been prescribed PROVENGE in the U.S. since 2010. Dendreon also is evaluating the use of PROVENGE in early-stage prostate cancer, with the hope of curing more men of the disease. Dendreon is headquartered in Seal Beach, Calif.

Excellos accelerates gene therapies by improving the quality, breadth, and variance of donor samples, and providing end-to-end cell therapy services: from customized collection to engineered working cell banks. Our proprietary Excellos 360 technology provides deep characterization of cells to better match patient and therapeutic development needs.

EXONBIO is a recombinant antibody and recombinant protein company. SPIN (Single Plasma Cell Interrogation) Technology for rabbit recombinant monoclonal antibody (rrMAb) development.

Formurex is a Pharmaceutical Contract Development and Manufacturing Organization (CDMO) with a mission to provide the best services in Preformulation, Formulation Development, Analytical, Stability and GMP Manufacturing. We Strive to distinguish our service by upholding our core values: quality, professionalism, respect, and innovation.

Founded in 1985, GeminiBio serves the global biotechnology industry, from basic research to commercial production, with a focus on helping our customers accelerate the development of life-enhancing biotherapeutics. The company focuses on producing cell culture products and solutions that help customers streamline their discovery, development, and production processes, and by making catalog and custom cGMP bioprocess liquids that radically simplify customers' manufacturing workflows – regardless of batch size. Located in West Sacramento, California, GeminiBio has two manufacturing facilities, comprising a total of 57,000 square feet. To meet the stringent needs of biotechnology research and production customers, the company's cell culture sera and bioprocess liquid manufacturing facilities are segregated between animal origin-free cGMP manufacturing and animal component cGMP manufacturing. GeminiBio is an ISO 13485 certified, FDA registered Class 1 Medical Device Manufacturer, aligned with 21 CFR Part 820.

We're a leading biotechnology company, providing streamlined or custom-tailored services for global clients in pharmaceutical, biotechnology industries, and academia. We've been a privately held family business since 1999, and have grown into a leading mammalian Contract Research, Development, and Manufacturing Organization (CRDMO). The CRDMO approach allows us to cover the entire spectrum of pre-clinical and clinical services - from the initial stages of target discovery and development, to cell line development, and manufacturing of mammalian therapeutic proteins, up to 1000 L scale. In 2023, we worked with more than 100 drug or vaccine development companies globally, producing more than 2400 different proteins. Clients trust us for custom-tailored solutions in every stage of drug substance development.

Izote Biosciences is a fermentation technology company with a superior approach to industrial biomanufacturing. Their anaerobic process enables a simpler, more productive method of producing bioplastics through aerobic microbial processes.

A business unit of JSR Corporation, JSR Life Science LLC is changing human health as a strategic partner and pathfinder for the life sciences industry. Rooted in a history of materials innovation, JSR LS provides specialized products, materials, and services to biopharmaceutical companies and academic researchers. Together with its world-class affiliates, JSR LS offers best-in-class integrated services that de-risk molecule selection, accelerate biologic development timelines, increase clinical success rates, and develop novel in vitro diagnostics. JSR LS’s global network of affiliates includes Crown Bioscience, KBI Biopharma, Inc., and MEDICAL & BIOLOGICAL LABORATORIES CO., LTD. The company operates R&D and applications labs, manufacturing facilities, and sales offices worldwide.

Levena Biopharma is a global ADC CRO/CDMO dedicated to advancing Antibody Drug Conjugate programs from discovery to the clinic and beyond. In 2013, Sorrento acquired Concortis Biosystems, establishing Levena as an independent, wholly-owned subsidiary of Sorrento Therapeutics to offer the scientific community access to our leading-edge linkers, payloads, and site-specific conjugation technologies. Our mission is to collaboratively develop conjugates that maximize the therapeutic potential of our clients' native or engineered antigen-targeting biomolecular carriers (antibodies, proteins and nucleic acids) and advance precision medicine options for patients with unmet clinical needs. We welcome discussing your projects and our capabilities at our world-class facilities in: -- San Diego (R&D Headquarters, 2013) -- Suzhou (CMC and cGMP, 2017) Levena provides small and large scale proof-of-concept (POC) conjugation services as well as complete ADC characterization using advanced analytical tools such as HPLC (HIC, SEC, RP), iCIEF and LC-MS, quality assessment (Drug-to-Antibody Ratio, purity via SDS-PAGE, aggregation, endotoxin, residual drug) and in vitro pharmacology for cytotoxicity studies. Expanding on IP from Concortis starting in 2008, we continue to maintain and grow our comprehensive, in-house portfolio of leading-edge ADC solutions, enabling Levena's world-class chemistry & conjugation teams to efficiently deliver constructs with unsurpassed quality and therapeutic potential. Our proprietary and non-proprietary ADC solutions include Linkers, Payloads, L-P chemistries and site-specific conjugation platforms [C-Lock™, K-Lock™ and C-Lock™/K-Lock™ for dual-drug delivery], enabling efficient development of mechanistically-defined ADCs with exacting, reproducible performance for safety, efficacy and clinical success.

List Labs specializes in the production of native toxins, recombinant proteins, bacterial fermentation, assay development, contract manufacturing, and biotherapeutics. List Labs produces C. difficile toxin A and toxin B, shiga toxins, cholera toxin, anthrax toxins (PA, LF, and EF), pertussis toxin, diphtheria toxin, CRM197, tetanus toxin, staphylococcal enterotoxin B, botulinum toxins as well as several types of lipopolysaccharides (LPS) or endotoxin for purchase by the research community.

Matrix Pharma Pvt. Ltd. was started in the year 2001 with a vision to be a leading innovative healthcare company. The company develops and offers a range of nutraceutical and pharmaceutical products, including dietary supplements, vitamins, and active pharmaceutical ingredients (API). Matrix Pharma aims to provide high-quality healthcare solutions to its customers and has cemented its position as an innovative player in the industry.

Medeologix is a contract development and manufacturing partner for minimally invasive devices, we empower MedTech companies globally to transform visionary concepts into mass-produced realities. Our unparalleled engineering expertise and seamless design-for-manufacturing integration accelerate our clients' product time to market, ensuring the swift delivery of innovative, high-quality medical devices that set new industry standards and ultimately enhance patient well-being.

For over 60 years, MeriCal has provided custom manufacturing and packaging services to the dietary supplement industry. Our state-of-the-art facilities located in Southern California and Ogden, UT offer a wide range of capabilities from research and development to turn-key manufactured & packaged products. MeriCal offers innovative nutritional products for today's world. We have over 230 years of combined industry experience on our team, along with a world-class formulation team you can trust. We globally source clinically researched ingredients to custom formulate unique solutions that meet our customer's needs. Today, we are a leading manufacturer and packaging leader in the dietary supplement industry. MeriCal offers extensive knowledge in the formulation and manufacturing of gummies, tablets, capsules, chewables, and powders for any size business or brand. From simple contract work to developing market-driven solutions, MeriCal does it all. Our goal is to exceed our customer's expectations in every endeavor. MeriCal embraces the core values of team work, respect, honesty and courtesy. As part of our ongoing commitment to providing a positive and healthy work environment for all of our employees, MeriCal offers a wide variety of employee benefits, including medical, dental and vision insurance, life insurance, holiday pay, PTO and a 401(K) retirement plan.

Minaris Regenerative Medicine is a global contract development and manufacturing organization for the production of cell and gene therapy products. We offer our clients clinical and commercial manufacturing services, development solutions, and technologies. With more than 20 years’ experience in the field of regenerative medicine, we are trusted partner ensuring scalability, delivering high quality results, and achieving cost effective manufacturing. Our state-of-the-art facilities in the United States, Europe, and Asia, as well as our committed employees, enable us to supply patients worldwide with lifechanging therapies. At Minaris, we are creating cell therapy miracles together. Minaris Regenerative Medicine is wholly owned by the Resonac Group.

We developed a new technology for enzymatic production of high quality, long and even functionalized DNA molecules, which will have a huge impact on industrial synthetic biology, precision diagnostics, therapeutics and nanotechnology. DNA oligonucleotides are commonly synthesized by solid phase, but after decades of fine-tuning and improvements in liquid handling, the upper limit of phosphoramidite-based oligo synthesis is now about 200-300 nucleotides, with further limitations in terms of purity and efficacy in presence of strong secondary structures or repeats. The advances and improvements in diagnostic and therapeutic systems based on nucleic acids are leading to a big and urgent need of highly pure and long DNA strands, and Moligo Technologies mission is to satisfy this necessity. In fact, thanks to our know-how, and to the capacity of experienced scientific and executive team, we are already able to synthesize, and very soon commercialize, single stranded oligonucleotides of thousands of bases with purity of about 99.9%.

nanoComposix is a world leading manufacturer of precisely engineered and highly characterized nanoparticles. Our mission is to help our customers bring nanotechnology-enabled products to market. Our multi-disciplinary technical teams provide rapid prototyping, characterization, integration, and scale-up solutions to accelerate R&D and commercialization for a wide variety of application areas including biodiagnostics, topical therapeutics, nanomedicine, antimicrobial coatings, and color engineering. Since 2004, nanoComposix has provided monodisperse and unagglomerated metal and metal-oxide nanomaterials to thousands of customers. Hundreds of different variants of material, size, shape, and surface are available as stock products and we have produced over 2000 custom core/shell, biofunctionalized, fluorescent, and magnetic nanocomposites to meet client specifications. All of our materials are supplied with certificates of analysis that include electron microscopy, hydrodynamic diameter, and optical data for each batch to guarantee products meet specifications. Contract manufacturing is performed on scales that range from small beakers to thousands of liters. Nanomaterials for medical devices and clinical trials are produced in our ISO 13485* and cGMP compliant cleanroom facility. By leveraging our unique library of nanomaterials, we aim to help our customers rapidly bring nanotechnology-enabled products from conception to commercialization. About Fortis Life Sciences: Fortis Life Sciences is a strategic platform providing capital, expertise, and operational resources enabling the growth and success of founder-led life sciences tools companies. Fortis Life Sciences was founded in 2020, with the vision of creating an exceptional life sciences company focused on offering world-class products coupled with a best-in-class customer experience. *For products manufactured under the scope of the ISO 13485 certification

Nanosyn is a privately held company founded in 1998, originally known as Nanoscale Combinatorial Synthesis. Established by chemists from the Soviet Union, Nanosyn focuses on providing efficient discovery chemistry services to pharmaceutical innovators, particularly emerging biotech firms. As a full-service Contract Development and Manufacturing Organization (CDMO), Nanosyn offers a variety of services to accelerate drug discovery. These include advanced chemistry solutions, biology services with high precision microfluidic-based assays, and support for the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and formulations. The company serves a diverse clientele, including small to mid-sized pharmaceutical companies, top 50 pharmaceutical firms, and academic institutions. Nanosyn has expanded its operations, including a branch in Research Triangle Park, North Carolina, and has a self-sustaining business model with reported revenues of $21.5 million. The company employs around 25 people and is recognized for its collaborative approach and commitment to delivering high-quality, cost-effective solutions.

Norac Pharma is a preferred California-based API contract research and manufacturing organization offering close partnership in bringing drugs to market through excellence in process development, analytical services and cGMP manufacture of Active Pharmaceutical Ingredients (API's) & intermediates. With over 40 years of API experience, including expertise in Controlled Substances and Potent Compounds, Norac Pharma delivers timely, efficient, and regulatory-compliant service in support of your API development needs. Our excellent track record in successful project delivery along with our extensive experience justifies your confidence in our ability to deliver, irrespective of target chemistry complexity. Exceptional Chemistry - Creative Solutions

Nutcracker Therapeutics is an RNA therapeutics company that has combined the power of advanced engineering with high-precision biosynthesis to deploy a complete RNA therapeutics platform. Armed with this high-tech advantage, we have developed a wholly owned pipeline of RNA therapeutic programs and established partnership initiatives with top clinical investigators at several leading institutions across the globe. With our platform’s ability to accelerate the development of life-changing RNA therapeutics, we seek to advance breakthrough RNA therapies at high velocity through all stages of development across a variety of indications. Our technology platform has the potential to significantly reduce costs and cycle times for RNA therapeutic development, with dramatic advantages in capacity scaling and point-of-care delivery over other RNA manufacturing approaches.

Polaris Pharmaceuticals is a biotechnology company that specializes in drug development for healthcare.

Polaris Pharmaceuticals, is a biopharmaceutical development and manufacturing organization (CDMO) specializing in biologics derived from microbial systems. We have manufactured clinical material for trials in the United States, Europe, China, Taiwan, Australia, and Korea. Polaris Pharma offers a comprehensive range of process and analytical development and high-quality cGMP pre-clinical and clinical manufacturing services. We offer services for the following: • Process Development • Master and Working Cell Bank Propagation • Pre-Clinical/Clinical Manufacturing • QC Method Development • In Process Testing • Release Testing • Stability Storage and Testing • Availability to provide high purity WFI and PW • Custom Buffer and Media Manufacturing • Contract Filling, Labeling, Inspection • Microbial Based Fermentation Products

RxSight® is an ophthalmic medical technology corporation headquartered in Aliso Viejo, California that has commercialized the world’s first and only adjustable intraocular lens (IOL) that is customized after cataract surgery. The company’s mission is to revolutionize the premium cataract surgery experience by allowing surgeons to partner with their patients to achieve optimized results for every unique eye.

Headquartered in Rancho Cordova, Calif., SK pharmteco is a global contract development and manufacturing organization specializing in the production of active pharmaceutical ingredients (APIs), advanced intermediates, and cell and gene therapy for the pharmaceutical industry. SK pharmteco is comprised of six companies: SK Biotek Korea, SK Biotek Ireland, AMPAC Fine Chemicals, AMPAC Analytical Laboratories in the U.S., Yposkesi and the Center for Breakthrough Medicines.

Teon is a clinical-stage company targeting metabolic signaling pathways and pioneering the development of GPCR immunotherapies in difficult-to-treat cancers.

Theragent is a full-service cGMP Contract Development and Manufacturing Organization delivering innovative cell and gene therapy products to clients and patients around the world. Our expert staff and state of the art facility serves as a “one stop shopâ€? for all biopharma stakeholders seeking assistance in manufacturing and product development. Theragent’s cGMP facility features four manufacturing clean suites equipped with Digital DES technology, in house QC/QA, Microbiology, MSAT capabilities, and custom designed ERP system with paperless MBRs for real time reporting.

True Diagnostics (True) designs and develops innovative POC diagnostic tests and devices based on its proprietary TrueDX™ Platform, which utilizes reliable and low-cost lab methods and its own proprietary or partnered biomarkers to offer rapid diagnoses to facilitate treatment decisions in point-of-care, point-of-incidence and remote-of-care settings. The TrueDX Platform's portability and affordability allow it to be easily adopted into emerging markets to provide accurate diagnosis within minutes. For the $21 billion point-of-care market, the power of the TrueDX Platform lies in its simplicity and flexibility. Tests have an 18-month or longer shelf life with no refrigeration required. The platform's flexible design additionally permits it to quickly commercialize a myriad of biomarkers discovered for cancer, autism, Alzheimer's, diabetes, drugs of abuse, infectious diseases, cardiac health, traumatic brain injury, viral and bacterial infections and more.

United Biologics, Inc. is a California-based medical device manufacturer with over 22 years of experience. The company specializes in creating anatomically precise silicone vascular models for medical simulation, training, and device development. Located in Irvine, California, United Biologics serves leading medical device companies worldwide, particularly in the intravascular therapy market. The company produces silicone replicas of human vasculature, which are used for medical training, device research and development, and marketing purposes. These models provide realistic training environments for physicians and serve as cost-effective alternatives to animal testing. United Biologics is recognized for its exclusive focus on silicone vascular replication and is trusted by top-tier medical device innovators.

Ametek Engineered Medical Components partners with the world’s top medical device manufacturers to design and manufacture state-of-the-art technology solutions for virtually every clinical application. Ametek Engineered Medical Components is a Division of Ametek, Inc., a leading global manufacturer of electronic instruments and electromechanical devices. Our broad array of design and manufacturing capabilities includes custom engineered interconnects, catheter components and systems, implanted lead components, ultrasound assemblies, and precision laser machining services. The source of Ametek Engineered Medical Components expertise is the result of the merger of two of the world’s top providers of medical technology design, manufacturing and logistics (Avicenna and TSE Inc). Our world-class team has a reputation for uncompromising quality and a commitment to complete customer satisfaction. AMETEK Engineered Medical Components is a Division of AMETEK, Inc., a leading global manufacturer of electronic instruments and electromechanical devices with sales near $4.0 billion.